Skip to Main Content

Paper Details

Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs.
Diabetes Care
45
2022
ASCVD, Atherosclerotic Cardiovascular Disease, GLP, GLP-1, GLP-1 RA, GLP-1 Receptor, Patients, SGLT2, SGLT2i, T2DM, Type 2 Diabetes, atherosclerotic cardiovascular disease, glucagon-like peptide 1 receptor, glucose, patients, sodium, sodium-glucose cotransporter 2, type 2 diabetes mellitus
Cardiovascular Diseases, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor, Humans, Hypoglycemic Agents, Sodium-Glucose Transporter 2 Inhibitors, Veterans
Author NameAffiliation
Dhruv MahttaBaylor College of Medicine
Dhruv MahttaMichael E. DeBakey Veterans Affairs Medical Center Health Services Research & Development Center for Innovations in Quality
David J RamseyMichael E. DeBakey Veterans Affairs Medical Center Health Services Research & Development Center for Innovations in Quality
Michelle T LeeBaylor College of Medicine
Michelle T LeeMichael E. DeBakey Veterans Affairs Medical Center Health Services Research & Development Center for Innovations in Quality
Lian ChenMichael E. DeBakey Veterans Affairs Medical Center Health Services Research & Development Center for Innovations in Quality
Mahmoud Al RifaiBaylor College of Medicine
Julia M AkeroydMichael E. DeBakey Veterans Affairs Medical Center Health Services Research & Development Center for Innovations in Quality
Elizabeth M VaughanBaylor College of Medicine
Elizabeth M VaughanBaylor College of Medicine
Michael MathenyGeriatrics Research Education and Clinical Care, Tennessee Valley Healthcare System VA
Michael E MathenyVanderbilt University Medical Center
Michael E MathenyGeriatrics Research Education and Clinical Care, Tennessee Valley Healthcare System VA
Michael MathenyVanderbilt University Medical Center
Karla Rodrigues do Espirito SantoHospital Israelita Albert Einstein
Sankar D NavaneethanSection of Nephrology and Institute of Clinical and Translational Research, Baylor College of Medicine
Sankar D NavaneethanMichael E. DeBakey Veterans Affairs Medical Center
Carl J LavieJohn Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine
Yochai BirnbaumBaylor College of Medicine
Christie M BallantyneBaylor College of Medicine
Christie M BallantyneBaylor College of Medicine
Christie M BallantyneBaylor College of Medicine
Christie M BallantyneBaylor College of Medicine
Laura A PetersenMichael E. DeBakey Veterans Affairs Medical Center Health Services Research & Development Center for Innovations in Quality
Laura A Petersen11Section of Health Services Research, Baylor College of Medicine
Salim S ViraniBaylor College of Medicine
Salim S ViraniMichael E. DeBakey Veterans Affairs Medical Center Health Services Research & Development Center for Innovations in Quality
Salim S ViraniBaylor College of Medicine
Salim S ViraniJohn Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine
Salim S ViraniMichael E. DeBakey Veterans Affairs Medical Center
  • 1 - 30

Datasets

Release 1.2